EUCTR2005-004527-19-GB进行中（未招募）1 期
Joint pain personalised treatment assessment to investigate the acceptability of modified release oxycontin for managing chronic pain in patients with osteoarthritis of the hip - Joint Pain PTA
MRC Health Services Research Collaboration0 个研究点目标入组 20 人开始时间: 2005年10月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •(1) Aged older than 65 years with symptomatic OA of the hip
- •(2) Chronic pain, defined as pain being present for at least three months, scoring 4 or more on an eleven point pain scale
- •(3) Able to walk six meters,
- •(4) Living in Bristol and been referred to the Avon Orthopaedic Centre in North Bristol Health Care Trust for total hip arthroplasty,
- •(5) Patients whose primary care clinicians have agreed to support the study
- •(6) Patients who are currently being prescribed NSAID for their pain
- •(7) Patients who give written informed consent to take part in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •(1) Those patients with severe co-morbidity whom it is believed would be unable to complete the trial,
- •(2) Previous intolerance/severe adverse events to Paracetamol or OxyContin,
- •(3) Current or previous history of alcohol abuse (assessed using the CAGE questionnaire)
- •(4) Current or previous history of problem drug use
- •(5) Current or previous history of a psychotic illness
- •(6) Patient who primary care clinicians considers may be at risk of additional central nervous system depressant effects with the study medication
- •(7) Lack of ability to take oral medication
- •(8) Patients with dementia
- •(9) Patients without primary care clinician approval
- •(10) Patients unable to give informed consent
- •(11) Patients without a reduction in pain by at least 2 points on an eleven-point pain scale within the two-week titration period.
- •(12) Patients who the researchers consider to be unsuitable to take part in the study for any other reason.
研究者
相似试验
招募中
1 期
Clinical observation on the treatment of joint swelling and pain due to the Fengtabuzu syndrome of RA by Dai medicine LongmengshahousaRAITMCTR2100004644Yunnan Hospital of Traditional Chinese Medicine
招募中
不适用
Testing the Relevance of Acupuncture Channel Theory in the Treatment of Myofascial Pain in the Upper Trapezius Muscle: A Randomised Controlled TrialMyofascial pain affecting the upper trapezius muscleMusculoskeletal - Other muscular and skeletal disordersACTRN12615001114538niversity of Technology Sydney80
进行中（未招募）
不适用
Individual pain management in day surgeryMedDRA version: 18.1Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 100000004863EUCTR2015-004515-20-FIVesa Kontinen
进行中（未招募）
Unknown
The benefits of continuous epidural infusion of ropivacaine in acute pancreatitisISRCTN82550530B?ch Mai Hospital72
尚未招募
Unknown
To assess pain and discomfort and use measures to decrease pain during surfactant administration in premature babiesCTRI/2024/05/066746Department of Neonatology Government medical College Chh Sambhajinagar